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Abstract An increase has been observed not only in the
absolute number of CT examinations but also in the length
of coverage and number of scanning phases, with the result
that exposure to ionising radiation from CT is becoming an
increasingly serious problem. The extent of the problem is
not entirely known and cannot be adequately addressed
without proper knowledge of all the phases that leads to the
effective dose calculation. In light of the growing aware-
ness of the issue of ionising radiation dose and the possible
risk for the individual and the population, there is a need
for radiologists, medical physicists and radiographers to
play an active role in dose management. In this review, the
authors try to delineate the problem in a consequential and
multifaceted way: radiation–patient interaction, possible
mechanisms of damage, main CT dose units, risk and its
quantification in the population, with the aim of optimising
the acquisition dose without diagnostic drawbacks. For an
‘‘up-to-date’’ use of CT, radiologists must know the dose
concerns for the single patient and population, and use the
CT apparatus with the best dose care; substitute CT with
other diagnostic techniques when possible, especially in
children; reduce the number/extension of scans and phases,
and the dose in single scans and single examinations.
Keywords CT  Radiation exposure  DLP  CTDI 
Radiation dose  Absorbed dose
Introduction
Exposure to ionising radiation in computed tomography
(CT) is a problem that is becoming progressively more
important as CT has acquired the role of a rapid, total-body
exploratory examination; it is very popular with both
patients and clinicians and is considered a ‘‘defensive’’ tool
in the diagnostic setting. An increase not only in the
absolute number of CT examinations, but also in terms of
both length of coverage and number of phases obtained
while scanning (baseline, arterial, sometimes two, venous,
late) has been observed [1, 2]. In some places, this is the
product of an expedient exchange of the ease and speed of
acquisition against appropriateness; however, there is an
abuse of the technique. This is often associated with the
adoption of suboptimal protocols, as is the case when
suitable technique modifications would allow inappropriate
exposures to be reduced without loss of quality. The
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problem is compounded by scanners that seem ‘‘friendly’’,
but are in fact becoming increasingly complex, favouring
the adoption of new practices without giving full regard to
the optimal use of dose reduction algorithms. It is thus
possible that a given instrument, in a single department, as
used by various operators for examination of a single body
district may yield doses that no longer depend predomi-
nantly on the limits of the machine but are operator
dependent, with the important implication that some
choices of the technicians and radiologists may not be
justifiable from diagnostic or dose limitation perspectives.
The extent of this problem is not entirely known and cannot
be adequately addressed without proper knowledge of all
the phases that lead to the effective dose calculation [3, 4].
However, there is no doubt that CT investigations are
increasing from every point of view: numbers of requests,
extension, and scan phases [1, 2].
In light of the growing awareness of the issue of radi-
ation dose and the possible risk for the individual and
population there is a need for radiologists, medical physi-
cists and radiographers to take on an active role in dose
management. The purpose of this review is to delineate the
problem in a consequential and multifaceted manner:
radiation–patient interaction, possible mechanisms of
damage, main CT dose units, risk and its quantification in
the population, with the aim of optimising the acquisition
dose without diagnostic drawbacks. This is extremely
important because of the increased awareness of patients,
as well as some recent decisions by the American College
of Radiology and legislative measures by individual
American states (California State ‘‘Dose Bill’’ [5]), which
change the professional and legal perspective on the
practice of CT, establishing a model that might be quickly
and uncritically emulated elsewhere.
Radiation damage
Ionising radiation interacts with the medium in which it
propagates yielding its energy. The energy delivery
modalities are described by the LET (linear energy trans-
fer). In the case of photons (X-rays), low LET radiation, it
is more probable that the interaction takes place with the
water molecules that are present in billions of copies in the
cell and represent 80 % of the weight. In this case, water
undergoes radiolysis with breaking up of the fundamental
bond and creation of two highly unstable and reactive
species such as free H. and OH. radicals. This primary
transfer, in living organisms, starts a complex series of
chemical reactions that are a prerequisite for cell changes
and the possible beginning of pathological alterations.
There is solid experimental evidence that DNA is the main
target of ionising radiation and that the damage is not
uniformly distributed along the molecule. Even repair is
influenced by the structure; in fact the transcription zones
are repaired faster than the silent zones, using enzymes and
co-factors that recognise the damage. Their lack does not
allow a timely repair influencing the survival and then the
probability of inducing mutations and carcinogenesis pro-
cesses [6].
The calculation of dose in CT
The rapid evolution of CT technology and the consequent
spread of new clinical applications have determined a deep
understanding of all information regarding CT dose cal-
culation and awareness of primary definitions of the
parameters for this estimate, which should be revised fol-
lowing the evolution of technology. Dose in CT was first
described using the computed tomography dose index
(CTDI). Now the original definition has been changed to
follow the technological improvements of CT. The CTDI is
a basic concept to understand dose measurement in CT and
is defined by:
CTDI ¼ 1
nT
ZZ2
Z1
DðzÞdz mGyð Þ
where: D (z) is the profile of the absorbed dose along the
z axis, n is the number of slices acquired in a single axial
rotation; the value of n may be less than or equal to the
maximum number of channels available on the system (for
example 64 for a multislice CT detector with 64 rows). T is
the nominal thickness of the tomographic section or the
amplitude of the group of detectors used in the case of
multislice CT (for example 5 mm acquisition for a
4 9 5 mm) (Table 1).
The CTDI can be measured using a 100-mm-long pencil
ionisation chamber, either in air (CTDIair) or in a dedicated
cylindrical polymethyl methacrylate (PMMA) phantom
simulating the head (head-H, 16 cm diameter) and the body
(body-B, 32 cm diameter) (Fig. 1). The CTDIair is char-
acteristic for each scanner and depends on tube current
intensity and voltage, beam collimation, filtration and the
Table 1 Computed tomography dosimetric values
Acronym symbol Unit measure
Dose in air CTDIair mGy
Locally absorbed dose CTDI100 mGy
CTDIw
CTDIvol
Total absorbed dose DLP mGy cm
Effective dose E mSv
CTDI computed tomography dose index, DLP dose length product
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geometric characteristics. Since dose distribution in the
phantom is generally not uniform, the measurements are
acquired at five different positions (in the centre and at the
four cardinal points), thus introducing the weighted CTDI
(CTDIw).
CTDIw ¼ 2
3
CTDI100;c þ 2
3
CTDI100;p
where CTDI100,c and CTDI100,p are measured at the centre
and at the periphery of the phantom, respectively, and the
index 100 indicates that the CTDI was measured with a
100-mm-long ionisation chamber. The CTDIw, however,
does not take into account the pitch used during a spiral
acquisition.
It was, therefore, necessary to define the volumetric CTDI,
the CTDIvol, i.e. CTDIw corrected for pitch. CTDIvol ¼ CTDIwpitch
It should be noted that the term ‘‘mAs’’ indicated on
some manufacturers’ consoles does not refer to true mAs,
but to mAs per rotation divided by the pitch. They are
commonly defined as ‘‘effective’’ mAs. In this case, the
CTDIvol will not change with pitch. Finally, as we do not
acquire a single-slice but a whole volume, we should also
consider the length of the scan and introduce a second dose
descriptor: the dose length product (DLP). The DLP pro-
vides information on the total exposure in the case of a
complete CT examination and is defined as the product of
the CTDIvol multiplied by the irradiated scan length ‘‘L’’.
The DLP expressed in mGy cm is:
DLP ¼ CTDIvol  L
The DLP is a comprehensive dose descriptor and allows
the assessment of risk by an estimation of the effective
dose using the appropriate conversion factors defined by
anatomical region. These conversion factors have been
defined in a document of the European Commission [7] and
updated after the release of ICRP 103 in 2007 to consider
the weighting factors for the different tissues shown in
Table 2 [8].
Obviously, this approach does not take into account the
individual patient size or the specific examination, but
allows a rough estimate of the effective dose for protocol
optimisation. However, there is a debate in the scientific
community about the fact that CTDIvol and consequently,
DLP are no longer adequate CT dose descriptors for a
number of reasons. The 100-mm-long ionisation chamber
is not suitable for multislice CT, because it is not long
enough to measure the wider beam width or to include the
contribution of the tails of the dose profile, resulting in an
underestimation of the measured CTDIvol. Also the com-
mercial phantoms used for CTDI measurements are shorter
than the chest of an adult and do not produce enough
scattered radiation, as would happen in a standard adult
(i.e. average dose received at the thorax underestimated up to
40 %). Finally, the CTDI is not suitable for CT exposures
where the patient remains immobile (or almost immobile)
during acquisition (cone-beam CT or perfusion studies), in
which case the value reported on the scanner console is an
overestimation of the mean absorbed dose in the scan volume.
These criticisms are in fact based on the false assump-
tion that the CTDIvol should estimate the dose to the
patient. In reality, the variety of patient types, scan proto-
cols and clinical applications is such that no single existing
phantom is able to accurately estimate the dose in all
patients. The estimations of patient dose for a ‘‘standard
man’’ will underestimate the dose received by a paediatric
or thin patient and overestimate the dose truly absorbed by
Fig. 1 Phantom used for measuring the computed tomography dose
index (CTDI) in CT. The 16-cm-diameter phantom is used for the
head and the 32-cm-diameter phantom is used for the body
Table 2 Conversion factors for calculation of effective dose by Huda
[8]
Body region Conversion factor (mSv mGy-1 cm-1)
Skull 0.0024
Neck 0.0053
Chest 0.020
Abdomen 0.016
Pelvis 0.014
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an obese subject. Furthermore, as the CTDIvol is displayed
on the console before starting a scan and recorded in the
dose report at the end of the examination, many users
assume that this is the individual patient dose. The CTDIvol
is no doubt still useful, but it should be clear that it is a
standardised phantom measurement of the CT system
output, which enables users to optimise and compare
radiation output between different protocols or different
scanners and not the real dose delivered to the patient.
Patient dose
Population dose from CT was a radiation protection con-
cern before the advent of ultrafast multidetector scanners;
in fact, diagnostic reference levels (DRLs) for CT exam-
inations have been defined in European guidelines [7] and
in the Italian law ‘‘D.Lgs. 87/00’’ since 2000 [9].
Even though DRLs should not be applied to individual
exposures but are reference doses for common examina-
tions, they can help to optimise radiation protection to
avoid unnecessarily high doses to the patient. They are
provided for four major anatomical regions: head, chest,
abdomen, and pelvis. For CT, the CTDIW and the DLP
were suitable quantities to be used as DRLs.
The Italian DRLs for CT are derived from a European
document based on a British study performed in the early
1990s. Since then, CT has undergone major evolution and
while CTDIW was a good metric at the time of single-slice
CT scanners, now it has been replaced by the CTDIvol
commonly displayed by the CT scanner console.
In 2006, Shrimpton et al. [10] published a national survey, a
review of patient doses from CT examinations in the UK in
2003, conducted on the basis of data received from over a
quarter of all UK scanners, of which 37 % had multislice
capability. The study collected data for protocols established
at each scanner for 12 common types of CT examination on
adults and children. The mean UK doses for adult patients
were in general lower by up to 50 % than previous ones,
although doses were slightly higher for multislice relative to
single-slice scanners. The relative increase in reference dose
was larger for scans of the head and the chest (high resolution).
These examinations both involve axial scanning with narrow
beam collimations, where beam penumbral effects and dif-
ferences in z axis geometrical efficiency between single and
multislice scanners were most pronounced [10].
A similar investigation, prior to the widespread adoption
of multislice CT was conducted in Italy in 2004 and pub-
lished in 2006 [11]. The survey was carried out for seven
adult clinical CT protocols, and showed that CTDIw and
DLP were always below the DRLs set by the European
guidelines [7]. Now the first Italian nationwide survey
about adult exposures from MDCT and including multi-
phase studies is at last available [12].
The subsequent advances in CT technology made it
possible to collect multiple images per rotation and to
acquire a given volume of data in a much shorter time
interval. This caused a general increase in the DLP, due to
the wide use of multiphase examinations and a larger
application in paediatric radiology.
In paediatric patients, CT radiation protection became
greater concern due to inherently higher radiosensitivity of
growing tissues (such as cartilage, red marrow), and chil-
dren’s longer life expectancy that involves a longer interval
in which one can develop a possible neoplasm.
Analysis of the risks associated with paediatric CT
mainly refers to the study by Brenner [13], which high-
lighted the increase in the probability of occurrence of
tumours when patient age decreased. It should be noted
that abdominal CT in a child increases the probability of
tumour occurrence to more than 20 %.
However, the main dosimetric aspects connected with
the use of CT in paediatrics are still poorly standardised:
1. The weighting factors for effective dose are not age
specific, and therefore, some authors suggest estimat-
ing them on an organ-by-organ basis [14].
2. The classic CT dose descriptors are based on phantoms
with diameter simulating the geometry of an adult and
introducing significant uncertainties in the evaluation
of organ doses in children.
Various tools have been used by different research
groups to perform size-dependent dose evaluations. Axel-
sons et al. [15] or Giacco et al. [16] used a physical
anthropomorphic phantom, while other investigators used
Monte Carlo voxelized phantoms [17]. In both methodol-
ogies, unlike what happens in the adult, the phantoms are
size and age specific [18]. Khursheed et al. [19] used the
Monte Carlo N-particle (MCNP) radiation transport code to
calculate normalised effective dose values for three dif-
ferent scanners and mathematical anthropomorphic phan-
toms with ages ranging from newborn to adult. They
demonstrated the high dependence on patient age and size:
the effective dose in a newborn was 1.5 times greater than
that of an adult for all types of examinations. Other dosi-
metric aspects associated with paediatric CT regard opti-
misation procedures [20].
Dose reduction systems
Dose reduction is one of the main problems in CT, and
many techniques have been developed to face this problem,
such as tube current modulation and voltage reduction.
Automatic dose modulation is based on the principle that
the operator decides on the desired image quality in terms
of ‘‘noise index’’, ‘‘reference mAs’’, or ‘‘reference image’’,
depending on the CT system manufacturer, and the scanner
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automatically selects the right tube current–time product
(mAs). The mAs are changed during the acquisition on the
basis of the different density and deepness of the anatom-
ical region being investigated. The system automatically
regulates tube current referring to scout images in the z
(longitudinal modulation) and x–y (transverse modulation)
axes.
The limits of these modalities in obtaining additional
dose reduction are determined by the inverse correlation
between mAs value and image noise. Using the conven-
tional reconstruction with filtered back-projection (FBP),
this limit seems impossible to overcome. Hence, a new
algorithm called iterative reconstruction (IR) has been
proposed by manufacturers—used in the past and aban-
doned because of the long reconstruction time imposed by
older computers—which is currently capable of additional
dose reduction [21]. Beister et al. [22] published an
extensive review of the different modalities of dose
reduction systems (Table 3).
Iterative modalities are based on mathematical algo-
rithms, which are not fully accessible because various
vendors produce them as ‘‘black boxes’’ mainly for the
commercial impact of these tools. However, it is possible
to divide these modalities into two types: those working on
the control of the images, using a statistical method for
noise reduction, and those directly managing the raw data
domain. The latter allow for a further dose reduction, but
imply a complex analysis with longer processing time [22].
Radiation dose and associated cancer risk
Although CT accounts for less than 19 % of radiological
examinations [3], its contribution in radiation dose for the
general population is becoming significantly higher. For
this reason, low-dose CT has become the subject of
numerous research publications. Epidemiological studies
failed to answer the various questions regarding cancer risk
related to low radiation levels; nonetheless the data were
robust, and the topic is challenging. For doses lower than
100 mSv (100 mGy with wR equal to 1), the risk calcula-
tion is based on the linear no-threshold model (LNT) that is
mainly accepted and adopted by the large majority of
international organisations in the field of radiation protec-
tion as ICRP, BEIR, NRPB, UNSCEAR, etc. [23–26].
In March 2007, the new ICRP no. 103 guideline modi-
fied the estimation of cancer risk from low radiation levels.
In fact, they increase the risk for the induction of somatic
damage in the population up to 6 % per Sv received,
remaining unchanged at 0.2 % for genetic risk. In the new
IRCP guidelines (no. 103), also a significant increase of
tissue weighting factors is established for breast tissue
(0.12 vs. 0.05) and a decrease for gonads (0.08 vs. 0.20)
[23].
The relation between age and risk is fully considered in
the BEIR VII publication of 2005 [24], which reports dif-
ferent risks of cancer induction related to life time (lifetime
attributable risk, LAR). LAR is updated using data from
atomic bomb survivors and more recent occupational and
epidemiological studies. LAR coefficients are calculated
according to age, sex and different organs for exposure to
100 mSv. For risk reduction, at low dose levels, in addition
to the linear model without threshold DDRF (dose and dose
rate effectiveness factor), a factor of 1.5 was used; con-
versely, the ICRP adopted a factor equal to 2 [23].
Estimation of cancer risk represents a complex problem
and many factors must be considered in cancer induction,
not only low-dose X-rays used in CT. So a more complete
approach should balance the ‘‘X-ray cancer risk’’ against
the ‘‘natural cancer risk’’.
Individual cancer risk is a multifactorial entity that is
difficult to estimate; however, age, sex and delivered
examination dose (in mSv) are important contributing
factors, as reported in the BEIR VII, IRCP and UNSCEAR
publications [23–26]. For instance, a 40-year-old male
subjected to an effective dose of 100 mSv (at least 4–5
total-body CT examinations) has, according to BEIR VII, a
risk of fatal cancer of 0.04 %. The risk is calculated by
multiplying the ‘‘natural’’ cancer risk (not considering
X-ray dose) by 0.4.
Nowadays, the risk of falling ill with cancer throughout
one’s lifetime is calculated at around 25 %, while the
radiation-related ‘‘estimated excess rate ratio’’ after an
exposure of 100 mSv is calculated as 0.01 (i.e. 0.04 9 0.25
plus an additional 1 %). Due to the greater sensitivity of
young subjects to radiation damage, the risk factor is 3–4
times more than in adults [27, 28].
In CT examinations, only body segments and not the
entire body (such as brain, chest and abdomen) are usually
exposed, so the risk calculation should take into account
Table 3 Iterative dose reduction system and corresponding acronym,
producer and year of commercialisation
Acronym Meaning Producer Year of
commercialisation
ASIR Adaptive statistical
iterative reconstruction
General
electric
2008
VEO
(MBIR)
Trade name General
electric
2009
IRIS Image reconstruction in
image space
Siemens 2009
SAFIRE Sinogram-affirmed
iterative reconstruction
Siemens 2010
iDose Trade name Philips 2009
AIDR Adaptive iterative dose
reduction
Toshiba 2010
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tissue-specific weighting factors (such as the breast in chest
exposure, which increases the risk).
Many publications consider it incorrect to calculate a
single individual risk, and underline the lack of sound
evidence of cancer risk for doses less than 50 mSv. Finally,
the risk estimation based on the Japanese nuclear bomb
survivors compared to the dose commonly used in CT is
considered questionable [29].
As the ICRP guidelines well outline, it is incorrect to
extrapolate an individual’s cancer risk [30], as the guide-
lines are for the cumulative cancer risk of a population.
Following Brenner’s publication [31, 32] some papers
calculated the effective cancer risk with a simple arith-
metical calculation (number of CT examinations multiplied
by mean exposure in mSv of the population) resulting in
impressive and overestimated rates of cancer related to
medical exposures in the general population [29]. Valid
evidence against this approach was described by Meer in
the US, who considered a population of 10 million
(Medicare) patients exposed to CT examinations
(1998–2005) and found a cancer risk between 0.02 and
0.04 % against the expected 1.5–2.0 %, applying the sim-
ple Brenner derived arithmetical calculation [33].
Two relevant epidemiological studies on low-dose
cancer risk have recently been published by Pearce in the
Lancet and Mathews et al. in the BMJ and regarded
British and Australian young subjects affected by leu-
kaemia and other solid cancers [34, 35]. Mathews et al.
compared the cancer incidence rates in individuals
exposed to a CT scan more than 1 year before any cancer
diagnosis with the incidence rates in unexposed individ-
uals. The study determined that ‘‘the increased cancer
incidence rates after CT exposure in these cohorts are
mostly due to irradiation’’ [35].
Another additional criticism of exponential cancer risk
is related to the evidence of the linear relation of the
damage in opposition to the nonlinear relation of the cel-
lular reparative mechanism, with consequent overestima-
tion of the damage [36]. Otherwise two different biological
theories negate the LNT model [37]. The first [36] con-
siders that there is no biological evidence for low dose. In
fact, data on atomic bomb survivors fit more with ‘‘a
nonlinear biological response’’ or ‘‘with threshold’’ mod-
els, than with LNT. The second theory refers to ‘‘horme-
sis’’, which in the cellular environment might promote an
adaptive mechanism for low doses determining higher
resistance of cells to radiation damage. Chen et al. [38]
underlined that the accidental chronic exposure to low
gamma radiation from Cobalt 60 determined protective
effects against tumours; in fact the expected tumour rate in
this population is lower than expected.
Although the scientific community is still debating the
effects of low dose levels, some misinterpretations of
scientific papers and some questionable CT practices have
resulted in internet forums and newspaper articles on ‘‘CT
linked to cancer’’ in single groups of patients. Media
pressure has probably induced the FDA and the California
State government to create protocols on CT exposure. The
FDA has established an initiative to reduce unnecessary
radiation exposure from medical imaging; the California
State government has promoted a law imposing a dose
report in every CT scan (Dose Bill) [5], including cases of
overdose and a strict annual control of the dose used for
every protocol by the medical physicist. In Italy as well,
several Regions are planning to introduce a dose report in
the radiological report. Moreover, a European Community
(EC) directive aiming to impose the dose report in the
radiological report (Council Directive 242, 2012 laying
down basic safety standards for protection against the
dangers arising from exposure to ionising radiation) is
under evaluation. Therefore, ‘‘risk denial’’ and ‘‘risk
strengthening’’ appear equally wrong, and the major
problem is represented by the information that the radi-
ologist should give to the patient. Are radiologists and
clinicians sufficiently prepared on the subject of cancer
risk?
Dose risk knowledge
‘‘Are all the subjects involved in CT prescription and
execution prepared on dose risk?’’ According to some
experiences published in the BMJ [39, 40], doctors work-
ing in the UK National Health Service have insufficient
knowledge about radiation protection, despite serious
continuous education programmes for health professionals
and a widely available publication for referring physicians
entitled ‘‘How to make the best use of the diagnostic
radiology department’’, in which the practice of dose
reduction is extensively described [41].
Introduction of radiation protection in medical school
programmes is also recommended in European guidelines
to all state members (European Commission Medical
Exposure Directive) [10, 42, 43].
In Italy, possible knowledge gaps among referring
physicians, radiographers and radiologists have not been
investigated despite the fact that since 1995 Italy has had
detailed legislation regulating the patient’s radiation
protection and operator education and training [43]. An
increased attention to the problem should be adopted in
young radiologists, who are more involved in emerging
radiation technologies and new applications. In June
2009, the American College of Radiology and the
Radiological Society of North America set up a task
force to increase radiation protection knowledge and
reduce unnecessary imaging in particular in paediatric
patients.
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Conclusions
Dose reduction in CT relies on the correct implementa-
tion/optimisation of protocols and everyday practice.
We can significantly reduce unnecessary radiation
exposure by being aware of patient risk and using all the
available resources in the CT apparatus to the best
advantage. To synthesise what radiologists are required
to do to ensure an ‘‘up-to-date’’ use of CT, we can state
that they should:
– Know the dose concerns for the single patient and
population, involving referring physicians in the
knowledge of possible risks and using the CT apparatus
with the best dose utilisation;
– Substitute CT with other diagnostic techniques when
possible especially in children;
– Reduce the number/extension of scans, phases, the dose
in single scans and examinations, also optimising
contrast and reducing costs.
Glossary and definitions
To facilitate reading of this review, this section recalls the
unit measures used in radiation protection and dosimetry in
alphabetical order.
Absorbed dose D is the measure of all types of ionising
radiation and is defined a D ¼ de
dm
where ‘‘de’’ represents
the mean energy deposited to the mass ‘‘dm’’ by the ion-
ising radiation. The adsorbed dose in SI system is measured
in Joule per kilogram (J kg-1) and named Gray (Gy).
The absorbed dose is calculated from the energy
deposited (e), does not reflect the single event of interac-
tion and its value is obtained as a mean on a generic ele-
ment of mass (dm).
The radiation damage for low dose levels is supposed to
be correlated with the value of adsorbed dose related to a
specific organ or tissue. To account for the different
modalities of radiation interaction and different radiation
sensitivities of tissue two other values need to be intro-
duced: the equivalent dose (HT) and the effective dose (E).
The unit measure is the same as the adsorbed dose J kg-1,
but it is called Sievert (Sv).
Diagnostic references levels (DRL) are defined dose
levels used in diagnostic and nuclear medicine for typical
groups of patients of standard body mass or a standard
phantom defined for different systems. The defined levels
should not be exceeded for standard procedures in normal
conditions (DLR for paediatric CT practice are not yet
available in Italy).
Equivalent dose HT is the result of the sum R of
adsorbed dose multiplied by the weight of radiation wR.
The type of radiation that interacts may contribute with a
factor of 1, 5, 10 in the case of photon, neutron, and alpha
particles, respectively.
Effective dose E is the sum of the equivalent dose
(considering radiation weighting factor) weighted for dif-
ferent organs or tissues (wT), according to the expression
E ¼ RT wTRRwRDT;R or E ¼ RTwTDT
The sum is considered with the weight of the global
detriment of all organs or tissue according to the weighted
value wT described in Table 4 [20].
These values are the result of epidemiological studies on
cancer induction in exposed populations and on the eval-
uation of the risk of hereditary effects according to ICRP
guideline 103 [23].
The principal uses of effective dose are prospective
dose evaluation way to plan and optimise radiation pro-
tection and to comply with dose limits in accordance with
guidelines and dose reference levels. It may also be
interesting to compare doses from different diagnostic
procedures and/or technologies or the use of similar
technologies or procedures across hospitals or countries to
compare technologies for the same medical investigations.
The effective dose, however, is not recommended for
epidemiological evaluation either for detailed retrospec-
tive analysis on exposure and risk of single individuals.
The interpretation of effective dose, in patients exposed
for medical purposes, remains complex especially when
organs or tissue is subjected to partial or heterogeneous
exposure.
Pitch in multislice spiral CT is defined as the ratio of the
table increment over the detector collimation. One can
assume that the detector collimation for each of N detector
arrays is the same, excluding cases of either different
collimations or combined ‘‘measurement row.’’
Conflict of interest Stefano Colagrande, Daniela Origgi, Giovanna
Zatelli, Andrea Giovagnoni, Sergio Salerno declare no conflict of
interest.
Table 4 Tissue weighting factors recommended by ICRP 103 [21]
Tissue wT RwT
Bone marrow (red), colon, lung, stomach, breast,
remaining tissuesa
0.12 0.72
Gonads 0.08 0.08
Urinary bladder, oesophagus, liver, thyroid 0.04 0.16
Bone surface, brain, salivary glands, skin 0.01 0.04
Total 1.00
a Remaining tissues adrenals, extrathoracic region, gall bladder,
heart, kidneys, lymphatic nodes, muscle, oral mucosa, prostate, small
intestine, spleen, thymus, uterus/cervix
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